相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease
Gagandeep Kaur et al.
CURRENT NEUROPHARMACOLOGY (2021)
Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease
Md. Tanvir Kabir et al.
MOLECULAR NEUROBIOLOGY (2021)
Exploring the role of mitochondrial proteins as molecular target in Alzheimer's disease
Swati Chadha et al.
MITOCHONDRION (2021)
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review
Tapan Behl et al.
TRANSLATIONAL NEURODEGENERATION (2021)
Organ-on-a-Chip: A New Paradigm for Drug Development
Chao Ma et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models
Ashok Iyaswamy et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2020)
Neuroprotection in Parkinson's disease: facts and hopes
Andras Salamon et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Matrix metallopeptidase expression and modulation by transforming growth factor-β1 in equine endometrosis
Anna Szostek-Mioduchowska et al.
SCIENTIFIC REPORTS (2020)
Targeting Aquaporin-4 Subcellular Localization to Treat Central Nervous System Edema
Philip Kitchen et al.
CELL (2020)
Matrix Metalloproteinases: How Much Can They Do?
Magnus S. Agren et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Editorial: Multiple Sclerosis - From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
Paulus S. Rommer et al.
FRONTIERS IN IMMUNOLOGY (2020)
New Insights Into the Pathogenesis of Alzheimer's Disease
Liyuan Fan et al.
FRONTIERS IN NEUROLOGY (2020)
Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges
Pauline Zipfel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Maryam Raeeszadeh-Sarmazdeh et al.
CELLS (2020)
Protective effects of thymoquinone against acrylamide-induced liver, kidney and brain oxidative damage in rats
Mohamed M. Abdel-Daim et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)
Nutraceuticals in Neurological Disorders
Rashita Makkar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Parkinson's disease: etiopathogenesis and treatment
Joseph Jankovic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Piezoelectric materials for ultrasound-driven dissociation of Alzheimer's β-amyloid aggregate structure
Jinhyeong Jang et al.
BIOMATERIALS (2020)
Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions
Tapan Behl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
Terry R. Suk et al.
MOLECULAR NEURODEGENERATION (2020)
Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance
Weixi Feng et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Design and Validation of a Human Brain Endothelial Microvessel-on-a-Chip Open Microfluidic Model Enabling Advanced Optical Imaging
Mootaz M. Salman et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Matrix metalloproteinases deregulation in amyotrophic lateral sclerosis
Jorge Luis Sanchez-Torres et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Alzheimer's Disease, Inflammation, and the Role of Antioxidants
Benjamin Sinyor et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2020)
Biosensors and bioassays for determination of matrix metalloproteinases: state of the art and recent advances
Zhen Lei et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity
Fabian Richter et al.
MABS (2019)
Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease
Yamini Madav et al.
BRAIN RESEARCH BULLETIN (2019)
Inhibitors of Mammalian Aquaporin Water Channels
Mohammed Abir-Awan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Archana Prasad et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
MONITORING THE EFFECTS OF VARIOUS COMBINATION OF SPECIFIC DRUG THERAPIES AT DIFFERENT STAGES OF ALZHEIMER'S DEMENTIA
Lavinia Purza et al.
FARMACIA (2019)
Matrix metalloproteinases in the CNS: interferons get nervous
Sameeksha Chopra et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Matrix metalloproteinases and ADAMs in stroke
Joan Montaner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
MMPs and ADAMs in neurological infectious diseases and multiple sclerosis
Lukas Muri et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders
Santiago Rivera et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
MMPs in learning and memory and neuropsychiatric disorders
Anna Beroun et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Disease modelling in human organoids
Madeline A. Lancaster et al.
DISEASE MODELS & MECHANISMS (2019)
Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques
Mehdi A. J. van den Bos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The energetic brain - A review from students to students
Melina Paula Bordone et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach
Mohamed M. Abdel-Daim et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Aquaporin-4 Surface Trafficking Regulates Astrocytic Process Motility and Synaptic Activity in Health and Autoimmune Disease
Silvia Ciappelloni et al.
CELL REPORTS (2019)
Matrix Metalloproteases as Influencers of the Cells' Social Media
Daniel Young et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The neuropathological diagnosis of Alzheimer's disease
Michael A. DeTure et al.
MOLECULAR NEURODEGENERATION (2019)
Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP
Laura Garcia-Gonzalez et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Neuroinflammation as a Common Feature of Neurodegenerative Disorders
Leonardo Guzman-Martinez et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
Hong-Meng Chuang et al.
MOLECULES (2019)
Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer's disease dementia: A systematic review and meta-analysis
Leonie C. P. Banning et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Polyproline chains destabilize the Alzheimer's amyloid-β protofibrils: A molecular dynamics simulation study
Pavan Krishna Kanchi et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Matrix metalloproteinase-3 in brain physiology and neurodegeneration
Anna Maria Lech et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Water channel pore size determines exclusion properties but not solute selectivity
Philip Kitchen et al.
SCIENTIFIC REPORTS (2019)
Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal
Oskar Zakiyanov et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding
Ricardo L. Sanz et al.
JOURNAL OF NEUROSCIENCE (2018)
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Marc Fakhoury
CURRENT NEUROPHARMACOLOGY (2018)
Prion-like seeding and nucleation of intracellular amyloid-β
Tomas T. Olsson et al.
NEUROBIOLOGY OF DISEASE (2018)
Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases
Helena Solleiro-Villavicencio et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
Geraldine Gelders et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Microglial Implication in Parkinson's Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
Cynthia Lecours et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
The physical approximation of APP and BACE-1: A key event in alzheimer's disease pathogenesis
Jichao Sun et al.
DEVELOPMENTAL NEUROBIOLOGY (2018)
Hypothermia increases aquaporin 4 (AQP4) plasma membrane abundance in human primary cortical astrocytes via a calcium/transient receptor potential vanilloid 4 (TRPV4)- and calmodulin-mediated mechanism
Mootaz M. Salman et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
Evette S. Radisky et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury
Daniela Impellizzeri et al.
JOURNAL OF NEUROTRAUMA (2017)
Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders
Patrycja Brzdak et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches
Maria Concetta Geloso et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects
Maxim Levin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation
Eugenia Gentile et al.
DRUG DISCOVERY TODAY (2017)
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease
Kevin Baranger et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Pathogenesis of amyotrophic lateral sclerosis
Sarah Morgan et al.
BRITISH MEDICAL BULLETIN (2016)
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives
Sumit Sarkar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers
Ralf G. Rempe et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
Agata Jablonska-Trypuc et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
NEURODEGENERATIVE DISEASES
Marie-Therese Heemels
NATURE (2016)
Hydrogen sulfide attenuates brain edema in early brain injury after subarachnoid hemorrhage in rats: Possible involvement of MMP-9 induced blood-brain barrier disruption and AQP4 expression
Shenglong Cao et al.
NEUROSCIENCE LETTERS (2016)
Matrix Metalloproteinases in Non-Neoplastic Disorders
Akinori Tokito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Beyond water homeostasis: Diverse functional roles of mammalian aquaporins
Philip Kitchen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Plasma inflammatory biomarkers for Huntington's disease patients and mouse model
Kuo-Hsuan Chang et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Matrix metalloproteinases as breast cancer drivers and therapeutic targets
Evette S. Radisky et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2015)
Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases
Marjana Brkic et al.
JOURNAL OF NEUROSCIENCE (2015)
Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism
V. Annese et al.
BRAIN STRUCTURE & FUNCTION (2015)
Multifaceted role of matrix metalloproteinases (MMPs)
Divya Singh et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
Matrix Metalloproteinases and Cancer - Roles in Threat and Therapy
Lalita Yadav et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Membrane-Type 1 Metalloproteinase Is Upregulated in Microglia/Brain Macrophages in Neurodegenerative and Neuroinflammatory Diseases
Anika Langenfurth et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Aquaporins: important but elusive drug targets
Alan S. Verkman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Manuel A. Friese et al.
NATURE REVIEWS NEUROLOGY (2014)
Neuronal Matrix Metalloproteinase-9 Is a Determinant of Selective Neurodegeneration
Artem Kaplan et al.
NEURON (2014)
Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice
Ethan A. Winkler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease
Xiang-Xiang Wang et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Role of Matrix Metalloproteinases in Migration and Neurotrophic Properties of Nasal Olfactory Stem and Ensheathing Cells
Adlane Ould-Yahoui et al.
CELL TRANSPLANTATION (2013)
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas
Helen Koennecke et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Astragaloside IV reduces cerebral edema post-ischemia/reperfusion correlating the suppression of MMP-9 and AQP4
Min Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Multiple sclerosis is primarily a neurodegenerative disease
Abhijit Chaudhuri
JOURNAL OF NEURAL TRANSMISSION (2013)
Microglial Activation and Antioxidant Responses Induced by the Parkinson's Disease Protein α-Synuclein
Dawn Beraud et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Relationship Between Cyclophilin A Levels and Matrix Metalloproteinase 9 Activity in Cerebrospinal Fluid of Cognitively Normal Apolipoprotein E4 Carriers and Blood-Brain Barrier Breakdown
Matthew R. Halliday et al.
JAMA NEUROLOGY (2013)
Neurovascular Matrix Metalloproteinases and the Blood-Brain Barrier
Ji Hae Seo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
MMP9: A novel function in synaptic plasticity
Magdalena Dziembowska et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Matrix Metalloprotease 8-Dependent Extracellular Matrix Cleavage at the Blood-CSF Barrier Contributes to Lethality during Systemic Inflammatory Diseases
Roosmarijn E. Vandenbroucke et al.
JOURNAL OF NEUROSCIENCE (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell et al.
NATURE (2012)
Synaptic circuit remodelling by matrix metalloproteinases in health and disease
George W. Huntley
NATURE REVIEWS NEUROSCIENCE (2012)
Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: Relevance to Parkinson's disease
Eun Jung Shin et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease (vol 2, e142, 2011)
C. Barcia et al.
CELL DEATH & DISEASE (2012)
Disruption of central nervous system barriers in multiple sclerosis
Jorge Ivan Alvarez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Amyotrophic lateral sclerosis: A neurovascular disease
Svitlana Garbuzova-Davis et al.
BRAIN RESEARCH (2011)
Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein
Wenjun Li et al.
BRAIN RESEARCH (2011)
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
Evelin L. Schaeffer et al.
CLINICS (2011)
How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Catherine Larochelle et al.
FEBS LETTERS (2011)
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Maria Bjerke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
Dong-Hee Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways
Vivek Swarup et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Role of matrix metalloproteinase-3 in neurodegeneration
Eun-Mee Kim et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Disruption of Neurovascular Unit Prior to Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis
Kazunori Miyazaki et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
The role of hypoxia-inducible factor-la, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury Laboratory investigation
Tetsuhiro Higashida et al.
JOURNAL OF NEUROSURGERY (2011)
Natural History of Multiple Sclerosis: Early Prognostic Factors
Ellen M. Mowry
NEUROLOGIC CLINICS (2011)
Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease
J. Duran-Vilaregut et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Long-Term Expression of Tissue-Inhibitor of Matrix Metalloproteinase-1 in the Murine Central Nervous System Does Not Alter the Morphological and Behavioral Phenotype but Alleviates the Course of Experimental Allergic Encephalomyelitis
Gioia E. M. Althoff et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Mei-Chen Liao et al.
BIOCHEMISTRY (2010)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
I. Niebroj-Dobosz et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease
Solveig Horstmann et al.
INTERNATIONAL PSYCHOGERIATRICS (2010)
Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice
Cynthia P. W. Soon et al.
NEUROMUSCULAR DISORDERS (2010)
Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
John P. Miller et al.
NEURON (2010)
Neisseria meningitidis Induces Brain Microvascular Endothelial Cell Detachment from the Matrix and Cleavage of Occludin: A Role for MMP-8
Alexandra Schubert-Unkmeir et al.
PLOS PATHOGENS (2010)
The impact of the extracellular matrix on inflammation
Lydia Sorokin
NATURE REVIEWS IMMUNOLOGY (2010)
Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases
Johannes Levin et al.
EXPERIMENTAL NEUROLOGY (2009)
Disruptions of Occludin and Claudin-5 in Brain Endothelial Cells In Vitro and in Brains of Mice with Acute Liver Failure
Feng Chen et al.
HEPATOLOGY (2009)
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice
Monica Garcia-Alloza et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
Martin A. Bruno et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice
Hiroyuki Mizoguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Linking neuron and skin: Matrix metalloproteinases in amyotrophic lateral sclerosis (ALS)
Lubin Fang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Gary A. Rosenberg
LANCET NEUROLOGY (2009)
DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS
J. S. Henkel et al.
NEUROLOGY (2009)
Distinct neuroinflammatory profile in post-mortem human Huntington's disease
Aurelio Silvestroni et al.
NEUROREPORT (2009)
DIVERSE ROLES OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF METALLOPROTEINASES IN NEUROINFLAMMATION AND CEREBRAL ISCHEMIA
E. Candelario-Jalil et al.
NEUROSCIENCE (2009)
Increased MMP-3 and CTGF expression during lipopolysaccharide-induced dopaminergic neurodegeneration
Justin A. McClain et al.
NEUROSCIENCE LETTERS (2009)
Neuroinflammation in the living brain of Parkinson's disease
Yasuomi Ouchi et al.
PARKINSONISM & RELATED DISORDERS (2009)
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
Maria Clara Pott Godoy et al.
BRAIN (2008)
Amyloid Precursor Protein Trafficking, Processing, and Function
Gopal Thinakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia
Moon-Sook Woo et al.
JOURNAL OF NEUROCHEMISTRY (2008)
A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells
D. H. Choi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
MMPs in the central nervous system: Where the good guys go bad
Smriti M. Agrawal et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia
Stefan Lorenzl et al.
INTERNATIONAL PSYCHOGERIATRICS (2008)
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Malu G. Tansey et al.
EXPERIMENTAL NEUROLOGY (2007)
Control of matrix metalloproteinase catalytic activity
Hyun-Jeong Ra et al.
MATRIX BIOLOGY (2007)
Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2007)
Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators
V. Wee Yong et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis
L. Morgan et al.
NEUROSCIENCE (2007)
Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-P stimulation via the PI3K/Akt pathway
Sachiko Ito et al.
EXPERIMENTAL GERONTOLOGY (2007)
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Jialiang Hu et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Matrix metalloproteinase-9 regulates TNF-α and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis
Mahmoud Kiaei et al.
EXPERIMENTAL NEUROLOGY (2007)
The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases
Benedicte Cauwe et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
TNF-α knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice
Chaohui Zhao et al.
NEUROBIOLOGY OF DISEASE (2007)
Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia
Robert K. Nuttall et al.
GLIA (2007)
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation
Yoon Seong Kim et al.
FASEB JOURNAL (2007)
Natural history of multiple sclerosis: risk factors and prognostic indicators
Sandra Vukusic et al.
CURRENT OPINION IN NEUROLOGY (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism
Ke-Jie Yin et al.
JOURNAL OF NEUROSCIENCE (2006)
Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ
Ping Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation
Kate J. Gurney et al.
NEUROBIOLOGY OF DISEASE (2006)
Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity
Anthony R. White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain
Y Gasche et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity
SE Meighan et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and-12 null mice
PH Larsen et al.
JOURNAL OF NEUROSCIENCE (2006)
Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation
AM Deschamps et al.
CARDIOVASCULAR RESEARCH (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases
Qing-Xiang Amy Sang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Physiological roles of glycerol-transporting aquaporins: the aquaglyceroporins
M. Hara-Chikuma et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Metalloproteinases: Mediators of pathology and regeneration in the CNS
VW Yong
NATURE REVIEWS NEUROSCIENCE (2005)
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
PM Carvey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Multiple roles for MMPs and TIMPs in cerebral ischemia
LA Cunningham et al.
GLIA (2005)
Matrix metalloproteinase-3: A novel signaling proteinase from apoptotic neuronal cells that activates microglia
YS Kim et al.
JOURNAL OF NEUROSCIENCE (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Crystal structures of MMPs in complex with physiological and pharmacological inhibitors
K Maskos
BIOCHIMIE (2005)
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
AC Newby
PHYSIOLOGICAL REVIEWS (2005)
The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis
M Demestre et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Matrix metalloproteinase-9, its tissue inhibitor (TIMP)-1 and CRP in Alzheimer's disease
M Inspector et al.
EUROPEAN NEUROLOGY (2005)
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis:: an [11C](R)-PK11195 positron emission tomography study
MR Turner et al.
NEUROBIOLOGY OF DISEASE (2004)
Neutralizing antibodies against IFN-β in multiple sclerosis:: antagonization of IFN-β mediated suppression of MMPs
F Gilli et al.
BRAIN (2004)
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
S Lorenzl et al.
NEUROMOLECULAR MEDICINE (2004)
β-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes
S Deb et al.
BRAIN RESEARCH (2003)
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases
S Lorenzl et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration
PL McGeer et al.
ANNALS OF NEUROLOGY (2003)
Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species
LY Qin et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease
S Lorenzl et al.
EXPERIMENTAL NEUROLOGY (2002)
Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia
S Rivera et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease
DC Wu et al.
JOURNAL OF NEUROSCIENCE (2002)
T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases
TA Newman et al.
BRAIN (2001)
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
RLP Lindberg et al.
BRAIN (2001)
Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation
T Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Multiple sclerosis:: elevated expression of matrix metalloproteinases in blood monocytes
M Kouwenhoven et al.
JOURNAL OF AUTOIMMUNITY (2001)
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis
W Beuche et al.
NEUROREPORT (2000)
Remarkable roles of proteolysis on and beyond the cell surface
CP Blobel
CURRENT OPINION IN CELL BIOLOGY (2000)
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease
A Leake et al.
NEUROSCIENCE LETTERS (2000)
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis
A Ishizuya-Oka et al.
JOURNAL OF CELL BIOLOGY (2000)
Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain
Y Yoshiyama et al.
ACTA NEUROPATHOLOGICA (2000)
Inflammatory mechanisms in Alzheimer's disease:: Inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists
CK Combs et al.
JOURNAL OF NEUROSCIENCE (2000)
分享论文
